CDK18
| Official symbol: | CDK18 |
| Full name: | cyclin dependent kinase 18 |
| Location: | 1q32.1 |
| Also known as: | PCTAIRE3, PCTK3 |
| Entrez ID: | 5129 |
| Ensembl ID: | ENSG00000117266 |
| Summary: | |
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
| Gscore (Amp): | 0.00 | | Gscore (Del): | 0.00 |
|
|
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall
|
|
Tissue specific
|
| |
| Total fusion occurrence: | 1 |
|
|
| Fusions detected in 1 cancer type(s) |
|
| |
|
|
|
| Functional class: | Kinase (protein kinase) |
| JensenLab PubMed score: | 12.13 (Percentile rank: 39.42%) |
| PubTator score: | 10.44 (Percentile rank: 40.83%) |
| Target development/druggability level: | TchemThese targets have activities in ChEMBL or DrugCentral that satisfy the activity thresholds detailed below. |
| Tractability (small molecule): | Clinical PrecedenceTargets with drugs in phase II or above; Pre-clinical targets |
| Tractability (antibody): | |
